Sinclair Pharma plc presenting at Piper Jaffray Annual Global
Healthcare Conference
16 November 2006, Godalming, UK - Sinclair Pharma plc (AIM: SPH.L),
the international specialty pharmaceutical company today announces
that its Chief Executive Officer, Dr Michael Flynn, and Chief
Financial Officer Jerry Randall, will be presenting at the Piper
Jaffray Health Care Conference at the Pierre Hotel, New York, on
Wednesday 29th November at 3.30pm.
A live webcast of Sinclair's presentation will be available at
http://www.piperjaffray.com/hcwebcast. The presentation and further
company information will also be available at www.sinclairpharma.com.
Sinclair Pharma plc
Sinclair Pharma plc is an international specialty pharmaceutical
company. It has a growing sales and marketing operation that is
already present in France, Italy, the UK, Spain and Portugal, and a
complementary marketing partner network that spans 60 countries.
Sinclair has proven expertise in acquiring or developing commercially
attractive and undervalued products, registering these products and
bringing them to market within a short time frame. The company
focuses on niche therapeutic areas and its current portfolio includes
products for dermatological conditions and oral health.
Enquiries:
Sinclair Pharma plc Tel: +44 1483 410 600
Zoe McDougall +44 7973 792 520
John Barrington-Carver Tel: +44 7831 655 630
Sinclair US
Mike Killeen Tel +1 972 478 4380
